The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawasaki, K.
Right arrow Articles by Nishijima, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawasaki, K.
Right arrow Articles by Nishijima, M.
The Journal of Immunology, 2001, 166: 11-14.
Copyright © 2001 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Gln22 of Mouse MD-2 Is Essential for Species-Specific Lipopolysaccharide Mimetic Action of Taxol1

Kiyoshi Kawasaki, Kazunori Gomi and Masahiro Nishijima2

Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan

MD-2 associates with the extracellular domain of Toll-like receptor 4 (TLR4) and greatly enhances LPS signaling via TLR4. Taxol, which mimics the action of LPS on murine macrophages, induces signals via mouse TLR4-MD-2, but not via human TLR4-MD-2. Here we investigated the molecular basis for this species-specific action of Taxol. Expression of mouse MD-2 conferred both LPS and Taxol responsiveness on human embryonic kidney 293 cells expressing mouse TLR4, whereas expression of human MD-2 conferred LPS responsiveness alone, suggesting that MD-2 is responsible for the species-specificity as to Taxol responsiveness. Furthermore, mouse MD-2 mutants, in which Gln22 was changed to other amino acids, showed dramatically reduced ability to confer Taxol responsiveness, although their ability to confer LPS responsiveness was not affected. These results indicated that Gln22 of mouse MD-2 is essential for Taxol signaling but not for LPS signaling.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. M. Zimmer, J. Liu, J. L. Clayton, D. S. Stephens, and J. P. Snyder
Paclitaxel Binding to Human and Murine MD-2
J. Biol. Chem., October 10, 2008; 283(41): 27916 - 27926.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. D. Snyder, R. E. Oberley-Deegan, K. L. Goss, S. A. Romig-Martin, L. L. Stoll, J. M. Snyder, and N. L. Weintraub
Surfactant protein D is expressed and modulates inflammatory responses in human coronary artery smooth muscle cells
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2053 - H2059.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Rallabhandi, A. Awomoyi, K. E. Thomas, A. Phalipon, Y. Fujimoto, K. Fukase, S. Kusumoto, N. Qureshi, M. B. Sztein, and S. N. Vogel
Differential Activation of Human TLR4 by Escherichia coli and Shigella flexneri 2a Lipopolysaccharide: Combined Effects of Lipid A Acylation State and TLR4 Polymorphisms on Signaling
J. Immunol., January 15, 2008; 180(2): 1139 - 1147.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
S. M Zimmer, S. M Zughaier, Y.-L. Tzeng, and D. S Stephens
Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4
Glycobiology, August 1, 2007; 17(8): 847 - 856.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Keestra, M. R. de Zoete, R. A. M. H. van Aubel, and J. P. M. van Putten
The Central Leucine-Rich Repeat Region of Chicken TLR16 Dictates Unique Ligand Specificity and Species-Specific Interaction with TLR2
J. Immunol., June 1, 2007; 178(11): 7110 - 7119.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. M. Doherty, P. K. Shah, M. Arditi, L. L. Stoll, G. M. Denning, and N. L. Weintraub
Lipopolysaccharide, Toll-Like Receptors, and the Immune Contribution to Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): e38 - e39.
[Full Text] [PDF]


Home page
BloodHome page
J. Pugin, S. Stern-Voeffray, B. Daubeuf, M. A. Matthay, G. Elson, and I. Dunn-Siegrist
Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock
Blood, December 15, 2004; 104(13): 4071 - 4079.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
K. Kawasaki, R. K. Ernst, and S. I. Miller
Deacylation and palmitoylation of lipid A by Salmonellae outer membrane enzymes modulate host signaling through Toll-like receptor 4
Innate Immunity, December 1, 2004; 10(6): 439 - 444.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. L. Stoll, G. M. Denning, and N. L. Weintraub
Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2227 - 2236.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Fujimoto, S. Yamazaki, A. Eto-Kimura, K. Takeshige, and T. Muta
The Amino-terminal Region of Toll-like Receptor 4 Is Essential for Binding to MD-2 and Receptor Translocation to the Cell Surface
J. Biol. Chem., November 12, 2004; 279(46): 47431 - 47437.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. Gon, Y. Asai, S. Hashimoto, K. Mizumura, I. Jibiki, T. Machino, C. Ra, and T. Horie
A20 Inhibits Toll-Like Receptor 2- and 4-Mediated Interleukin-8 Synthesis in Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol., September 1, 2004; 31(3): 330 - 336.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. N. Kennedy, G. E. D. Mullen, C. A. Leifer, C. Lee, A. Mazzoni, K. N. Dileepan, and D. M. Segal
A Complex of Soluble MD-2 and Lipopolysaccharide Serves as an Activating Ligand for Toll-like Receptor 4
J. Biol. Chem., August 13, 2004; 279(33): 34698 - 34704.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S.-i. Saitoh, S. Akashi, T. Yamada, N. Tanimura, M. Kobayashi, K. Konno, F. Matsumoto, K. Fukase, S. Kusumoto, Y. Nagai, et al.
Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization
Int. Immunol., July 1, 2004; 16(7): 961 - 969.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kawasaki, R. K. Ernst, and S. I. Miller
3-O-Deacylation of Lipid A by PagL, a PhoP/PhoQ-regulated Deacylase of Salmonella typhimurium, Modulates Signaling through Toll-like Receptor 4
J. Biol. Chem., May 7, 2004; 279(19): 20044 - 20048.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Oshiumi, M. Sasai, K. Shida, T. Fujita, M. Matsumoto, and T. Seya
TIR-containing Adapter Molecule (TICAM)-2, a Bridging Adapter Recruiting to Toll-like Receptor 4 TICAM-1 That Induces Interferon-{beta}
J. Biol. Chem., December 12, 2003; 278(50): 49751 - 49762.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Re and J. L. Strominger
Separate Functional Domains of Human MD-2 Mediate Toll-Like Receptor 4-Binding and Lipopolysaccharide Responsiveness
J. Immunol., November 15, 2003; 171(10): 5272 - 5276.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Pinhal-Enfield, M. Ramanathan, G. Hasko, S. N. Vogel, A. L. Salzman, G.-J. Boons, and S. J. Leibovich
An Angiogenic Switch in Macrophages Involving Synergy between Toll-Like Receptors 2, 4, 7, and 9 and Adenosine A2A Receptors
Am. J. Pathol., August 1, 2003; 163(2): 711 - 721.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Kawasaki, H. Nogawa, and M. Nishijima
Identification of Mouse MD-2 Residues Important for Forming the Cell Surface TLR4-MD-2 Complex Recognized by Anti-TLR4-MD-2 Antibodies, and for Conferring LPS and Taxol Responsiveness on Mouse TLR4 by Alanine-Scanning Mutagenesis
J. Immunol., January 1, 2003; 170(1): 413 - 420.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Muroi, T. Ohnishi, and K.-i. Tanamoto
MD-2, a Novel Accessory Molecule, Is Involved in Species-Specific Actions of Salmonella Lipid A
Infect. Immun., July 1, 2002; 70(7): 3546 - 3550.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Re and J. L. Strominger
Monomeric Recombinant MD-2 Binds Toll-like Receptor 4 Tightly and Confers Lipopolysaccharide Responsiveness
J. Biol. Chem., June 21, 2002; 277(26): 23427 - 23432.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M A Moscarello, B Mak, T A Nguyen, D D Wood, F Mastronardi, and S K Ludwin
Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination
Multiple Sclerosis, April 1, 2002; 8(2): 130 - 138.
[Abstract] [PDF]


Home page
J. Immunol.Home page
K. Gomi, K. Kawasaki, Y. Kawai, M. Shiozaki, and M. Nishijima
Toll-Like Receptor 4-MD-2 Complex Mediates the Signal Transduction Induced by Flavolipin, an Amino Acid-Containing Lipid Unique to Flavobacterium meningosepticum
J. Immunol., March 15, 2002; 168(6): 2939 - 2943.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
S. H. Diks, S. J.H. van Deventer, and M. P. Peppelenbosch
Invited review: Lipopolysaccharide recognition, internalisation, signalling and other cellular effects
Innate Immunity, October 1, 2001; 7(5): 335 - 348.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.